Skip to content

Time left to comment:


Archive for 2013

The Partnership for Safe Medicines 2013 Interchange

    PSM’s 4th annual Interchange conference was held October 24, 2013 at the Knight Conference Center at The Newseum, 555 Pennsylvania Av., NW, Washington, D.C..     Keynote Speaker: Dr. Ilisa Bernstein, Deputy Director of the Office of Compliance in the Center for Drug Evaluation and Research (FDA) Each year, the PSM Interchange brings…


Nemlekar P, Shepherd M*, Lawson K, and Rush S. Web-Based Survey to Assess the Perceptions of Managed Care Organization Representatives on Use of Copay Subsidy Coupons for Prescription Drugs. J Manag Care Pharm. 2013;19(8):602-08.

ABSTRACT BACKGROUND: Promotion of prescription drug coupons and vouchers by pharmaceutical manufacturers has increased in recent years. These coupons and vouchers usually subsidize patients’ cost-sharing obligations. In other words, drug companies pay for a patient’s portion of the drug cost, and the remaining cost is paid by the patient and the patient’s health plan. This…


Florida Man Sent to Prison for 2 Years for Selling Unapproved Imported Cancer Medication

A Florida resident, Martin Paul Bean III has been sentenced to 2 years in prison in a complex counterfeit cancer drug scheme that purchased bulk cancer medications from Pakistan, India, and Turkey. The misbranded oncology drugs were then repackaged and sold as genuine, FDA-approved medications to medical practices throughout the United States. Repackaging work was…


Will the PSM 2013 Interchange Still Happen During the Government Shutdown?

You can count on it. The criminals who counterfeit drugs and endanger American patients haven’t stopped making and selling fake drugs during the shutdown. There is more need for a counterfeit drug conference now than ever. The 2013 Interchange will include: Patient advocates who represent patients whose lives depend on getting genuine medication Journalists who…


New Research on Threats to the Secure Drug Supply Chain at 2013 Interchange

2013 Interchange will feature new research from Carl L. Alsberg Fellow, Tim K. Mackey, and in-progress research from PSM Board member Marv Shepherd. As part of the Partnership for Safe Medicines continuing effort to inform the both the public and medical professionals about the dangers of counterfeit medication, we’re presenting two new research studies on…


Keynote Speaker Announced for Counterfeit Drug Conference

The Partnership for Safe Medicines is pleased to announce Deputy Director Ilisa Bernstein as the keynote speaker of the 2013 Interchange on October 24, in Washington, DC. Dr. Ilisa Bernstein is the Deputy Director of Office of Compliance in the Center for Drug Evaluation and Research at the U.S. Food and Drug Administration (FDA). She…


Partnership For Safe Medicines India Holds Training Session Aimed at Combating Spurious Medication

Partnership for Safe Medicines India brings together pharmaceutical, patient safety, and government enforcement organizations for their training workshop focused on protecting patients from false or spurious medicines. Bejon Misra, founder of the Partnership for Safe Medicines India will be our luncheon speaker at the 2013 Interchange October 24th in Washington D.C. Register today! On August 23rd 2013,…


PSM’s Scott LaGanga to Japan Medical Association: Counterfeit Medicines a Global Health Menace

PSM Executive Director Urges Greater International Cooperation in Major Address to the Japan Medical Association TOKYO, JAPAN (September 19, 2013) – Partnership for Safe Medicines Executive Director Scott LaGanga stressed the urgent need for greater global education and collaboration to fight the growing health threat posed by counterfeit and substandard medicines in an address to…


Shepherd M*. Examination of Why Some Community Pharmacists Do Not Provide 72-Hour Emergency Prescription Drugs to Medicaid Patients When Prior Authorization Is Not Available. J Manag Care Pharm. 2013;19(7):523-33.

BACKGROUND: Existing federal law requires that a 72-hour emergency supply of a prescription drug be dispensed to Medicaid patients when prior authorization (PA) is not available and the medication is needed without delay. The pharmacist’s role is to contact prescribers and inform them that PA is needed. If the prescriber cannot be reached, the pharmacist can dispense a 72-hour emergency supply.

OBJECTIVES: To determine (a) the reasons why some community pharmacy owners/managers, staff pharmacists, and technicians are not compliant with the law; (b) how often the decision is made; and (c) estimate how often pharmacies do not dispense the 72-hour emergency supply when PA is not available.

Scroll To Top